- Understand the contemporary trends of the management of hypertension in Canada.
- Appreciate the critical role of ACE inhibitors in cardiometabolic risk reduction.
- Understand the evidence supporting antihypertensive therapy and renal protection.
MD, PhD, FRCSC, FAHA
Division of Cardiac Surgery, St. Michael’s Hospital
Professor Surgery and Pharmacology & Toxicology, University of Toronto
David H Fitchett
MD, FRCC, FACC, FESC
Division of Cardiology, St. Michael’s Hospital
Associate Professor of Medicine, University of Toronto
Philip A McFarlane
MD, PhD, FRCPC
Medical Director of Home Dialysis
Medical Co-Director, Multidisciplinary Diabetes Complications Clinic
Chief Nephrologist, Live Kidney Donor Program, St. Michael’s Hospital
Assistant Professor of Medicine, University of Toronto